1. Home
  2. ALAR vs CELU Comparison

ALAR vs CELU Comparison

Compare ALAR & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alarum Technologies Ltd.

ALAR

Alarum Technologies Ltd.

HOLD

Current Price

$6.96

Market Cap

43.7M

Sector

Technology

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.13

Market Cap

35.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALAR
CELU
Founded
2013
2016
Country
Israel
United States
Employees
N/A
123
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.7M
35.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ALAR
CELU
Price
$6.96
$1.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$14.00
$6.00
AVG Volume (30 Days)
29.8K
25.1K
Earning Date
05-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$24.51
N/A
Revenue Next Year
$33.43
$76.00
P/E Ratio
$44.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.50
$1.01
52 Week High
$18.00
$4.35

Technical Indicators

Market Signals
Indicator
ALAR
CELU
Relative Strength Index (RSI) 55.23 35.50
Support Level $6.34 $1.04
Resistance Level $7.76 $1.44
Average True Range (ATR) 0.46 0.06
MACD 0.11 -0.02
Stochastic Oscillator 65.10 3.03

Price Performance

Historical Comparison
ALAR
CELU

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment: web data collection. Geographically, it derives maximum revenue from China, followed by the United States, Europe, Hong Kong, Asia-Pacific, U.K. Virgin Islands, Israel, United Arab Emirates, Middle East & Africa and other.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: